Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Umbelliferone is a naturally occurring **coumarin derivative**, chemically known as **7-hydroxycoumarin**. It is found in many plants, especially those in the Umbelliferae and Rutaceae families. As a plant secondary metabolite, **umbelliferone displays a broad range of biological activities** and is used in research, cosmetics, and potentially as a therapeutic agent. It is known for its **antioxidant, anti-inflammatory, antimicrobial, antidiabetic, antitumor, and neuroprotective** properties[3][5][7]. Mechanistically, umbelliferone acts as a **potent inhibitor of type 3 17β-hydroxysteroid dehydrogenase**, impacting steroid metabolism[1], and **inhibits oxidative stress, inflammation, and apoptosis** in biological systems[7]. It also has uses in industry, including as a UV filter in sunscreens, fluorescent probe, optical brightener, and dye laser component[1][5]. Umbelliferone is not approved as a pharmaceutical drug but is widely studied for its therapeutic potential in diseases like diabetes, cancer, neurodegenerative disorders, and inflammatory diseases[3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on umbelliferone.